Winton Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-15,353
Closed -$125K 1129
2019
Q1
$125K Buy
+15,353
New +$125K ﹤0.01% 1015